- Home
- ALVO vs HBI Comparison
ALVO vs HBI Comparison
Compare ALVO & HBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVO
- HBI
- Stock Information
- Founded
- ALVO 2013
- HBI 1901
- Country
- ALVO Luxembourg
- HBI United States
- Employees
- ALVO N/A
- HBI N/A
- Industry
- ALVO Biotechnology: Pharmaceutical Preparations
- HBI Clothing/Shoe/Accessory Stores
- Sector
- ALVO Health Care
- HBI Consumer Discretionary
- Exchange
- ALVO Nasdaq
- HBI Nasdaq
- Market Cap
- ALVO 2.5B
- HBI 2.4B
- IPO Year
- ALVO N/A
- HBI 2006
- Fundamental
- Price
- ALVO $7.84
- HBI $6.64
- Analyst Decision
- ALVO Strong Buy
- HBI Hold
- Analyst Count
- ALVO 2
- HBI 5
- Target Price
- ALVO $14.00
- HBI $6.60
- AVG Volume (30 Days)
- ALVO 352.1K
- HBI 7.2M
- Earning Date
- ALVO 11-12-2025
- HBI 11-06-2025
- Dividend Yield
- ALVO N/A
- HBI N/A
- EPS Growth
- ALVO N/A
- HBI N/A
- EPS
- ALVO 0.22
- HBI 0.25
- Revenue
- ALVO $562,478,000.00
- HBI $3,540,309,000.00
- Revenue This Year
- ALVO $34.94
- HBI $1.61
- Revenue Next Year
- ALVO $39.55
- HBI N/A
- P/E Ratio
- ALVO $36.05
- HBI $26.36
- Revenue Growth
- ALVO 82.19
- HBI 2.95
- 52 Week Low
- ALVO $7.35
- HBI $3.96
- 52 Week High
- ALVO $13.70
- HBI $9.10
- Technical
- Relative Strength Index (RSI)
- ALVO 40.91
- HBI 45.18
- Support Level
- ALVO $7.77
- HBI $6.71
- Resistance Level
- ALVO $8.50
- HBI $7.03
- Average True Range (ATR)
- ALVO 0.29
- HBI 0.15
- MACD
- ALVO -0.08
- HBI -0.04
- Stochastic Oscillator
- ALVO 5.49
- HBI 18.75
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.
About HBI Hanesbrands Inc.
Hanesbrands manufactures basic and athletic apparel under brands including Hanes, Playtex, Maidenform, Bali, Berlei, and Bonds. The company sells wholesale to discount, midmarket, and department store retailers as well as direct to consumers through stores and e-commerce. Hanesbrands is vertically integrated, as it produces nearly 75% of its products in company-controlled factories in more than three dozen nations. Hanesbrands distributes products in the Americas and Asia-Pacific. The company was founded in 1901 and is based in Winston-Salem, North Carolina. Hanesbrands has agreed to be acquired by Canadian rival Gildan.